<DOC>
	<DOCNO>NCT01617590</DOCNO>
	<brief_summary>This study intend assess efficacy safety different Disease-Modifying Antirheumatic Drugs cycle combination regimen use American College Rheumatology ( ACR ) criteria 20 % improvement symptom ( ACR20 ) manage active adult rheumatoid arthritis .</brief_summary>
	<brief_title>Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>RA patientsï¼š Male female patient age 18 75 year ( inclusive ) . Body weight 50 100 kg ( inclusive ) . Post menopausal surgically sterile female patient allow . Female patient childbearing potential may participate already stable dose methotrexate . Additional birth control detail provide screen . Male patient must use effective contraception method study least 2 month follow completion/discontinuation study . Diagnosis RA , classify American Rheumatism Association 1987 revise criterion . Active disease evaluation ( DAS 28 &gt; 3.2 ) . Patients use steroids enrollment , dose 30mg/d , remain unchanged 30days . Without use disease activity control drug . Get informed consent . Advanced patient severe joint disability . Pregnant breast feed female patient . Patients severe primary disease impairment heart , brain , lung , liver ( ALT AST &gt; 1.5 normal value ) , kidney ( sCr &gt; normal value ) , endocrine , hematology system . Concomitant rheumatic disease . Alcohol take drug abuse patient . Patients congestive heart failure , QT prolongation syndrome poorly control diabetes mellitus . Patients history QTc prolongation exclude . Patients receive intraarticular systemic corticosteroid injection require treatment acute RA flare ( part regular therapeutic regimen ) within 4 week prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>RA</keyword>
	<keyword>Leflunomide</keyword>
	<keyword>Methotrexate</keyword>
</DOC>